USPTO serial 97047498
ENTIA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 6, 2022
- Examiner
- DUBRAY, KATHERINE M
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with ENTIA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Scott M. Lowry
Scott M. Lowry LOWRY BLIXSETH APC30423 Canwood St., Ste. 215Agoura Hills, CA 91301UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals for use in industry and science; Chemical reagents for use in analytical tests, other than for medical or veterinary use; Laboratory testing kits for research purposes, namely, blood testing; Diagnostic testing preparations other than for medical use; Testing reagents for scientific use; Diagnostic preparations for scientific or research use other than for medical use; Diagnostic reagents for laboratory use; Diagnostic reagents for clinical or medical laboratory use | ACTIVE | — |
| 005 | Diagnostic preparations for medical or veterinary purposes; Pharmaceutical preparations, namely, preparations for treating blood disease; Reagents for analytical purposes, namely, clinical medical reagents; Chemical reagents for analytical veterinary purposes; Diagnostic proteins for clinical or medical laboratory analysis, namely, protein arrays for medical diagnosis purposes; Reagents for medical use; Biological reagents for medical use; Chemical diagnostic reagents for medical use; Chemical reagents for medical or veterinary purposes; Chemical reagents for use in medicine; Diagnostic reagents for medical use; Reagents for blood grouping, namely, chemical reagents for medical purposes; Chemical preparations for testing blood for medical purposes | ACTIVE | — |
| 009 | Recorded computer firmware for analyzing, recording and organizing test results from medical diagnostic and imaging equipment; Downloadable software for use in medical, health and/or wellbeing monitoring; Recorded computer software for use for use in medical, health and/or wellbeing data collection; Downloadable mobile application software for operating medical imaging apparatus; Downloadable mobile applications and computer software for data communication and translating and transmitting data sold therewith; Downloadable networking and social networking software; Data and file management and database management downloadable software; Recorded computer software for use in medical, health and/or wellbeing monitoring; Downloadable computer software for use with medical testing kits and devices; Mobile phone apps, namely, downloadable software applications for use in connection with sorting and organizing diagnostic data; Downloadable mobile phone software applications for use in medical, health and/or wellbeing monitoring; Downloadable mobile phone software applications for use with medical testing kits and devices; Downloadable mobile phone software applications for use with blood testing kits and devices; Data storage programs, namely, recorded computer programs for use in electronic storage of data; Downloadable data storage programs for use in medical, health and/or wellbeing monitoring; Downloadable data storage programs for use with medical testing kits and devices; Downloadable data storage programs for use with blood testing kits and devices; Downloadable cloud computing software for managing virtual machines on a cloud computing platform; Downloadable cloud computing software for use in medical, health and/or wellbeing monitoring; Downloadable cloud computing software for use with medical testing kits and devices; Downloadable cloud computing software for use with blood testing kits and devices; Measuring, detecting, monitoring and controlling devices, namely, laboratory devices for detecting genetic sequences, thermometers, and electrical controlling devices | ACTIVE | — |
| 010 | Testing apparatus for medical purposes, namely, apparatus for DNA and RNA testing for medical purposes; Medical analytical apparatus for medical purposes, namely, skin moisture analyzers for medical purposes; Analytical instruments for medical use, namely, electrochemical sensors for determination of analyte concentrations in fluids for medical purpose; Diagnostic, examination and monitoring equipment, namely, cytometers for medical diagnostic use, hematology analyzers for medical diagnostic uses; Medical diagnostic instruments, namely, medical diagnostic instruments for the analysis of body fluids; Diagnostic apparatus for medical purposes, namely, radiological apparatus for diagnostic and medical purposes, namely, magnetic resonance imager; Apparatus for blood analysis; Blood testing equipment, namely, blood sampling tubes; Apparatus for taking blood; Parts and fittings for all the aforementioned goods, namely, apparatus for taking blood samples, blood collection bags for medical purposes, blood drawing apparatus and blood component separation apparatus for medical purposes | ACTIVE | — |
| 042 | Research and development of new products; Medical and pharmacological research services; Scientific research; Scientific research for medical purposes; Chemical technological research; Scientific genetic research; Laboratory research in the field of pharmaceuticals; Technical data analysis services, namely, data automation and collection service using proprietary software to evaluate, analyze and collect medical data; Laboratory testing, namely, laboratory research services relating to pharmaceuticals; Chemical analysis; Biochemical analysis; Chemical analysis services for use in evaluation; Blood analysis services; Research and development in the field of diagnostic preparations; Providing information on clinical studies via an interactive website; Computer software technical support in the nature of troubleshooting computer software problems, remote management of information technology systems of others and help-line services in the nature of help desk services relating to medical and surgical apparatus and instruments and medical diagnostic and imaging equipment | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Entia Ltd
- Other trademarks owned by Entia Ltd
- Other trademarks owned by Entia Ltd
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named ENTIA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 6, 2022 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Dec 6, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 20, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 20, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 31, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 12, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 1, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 29, 2022 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 29, 2022 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 29, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 21, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 21, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 21, 2022 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jun 17, 2022 | ALIE | ASSIGNED TO LIE | — |
| Jun 9, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 8, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jun 8, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 8, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 7, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 7, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 7, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 25, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 27, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 30, 2021 | NWAP | NEW APPLICATION ENTERED | — |